Expected to enable production of 100,000 doses annually within the next decade
FDA Clears Hologic's MammoSite(R) ML Radiation The MammoSite ML (multi-lumen) device offers more women the option of completing their radiation treatment in just five days.
Provides 'adequate control' of prostate cancer, averts side effects of conventional treatments
The patents concern positive pressure airway devices
Best Particle Therapy plans to bring smaller footprint system to market in two to three years
CIRS appoints new sales manager
Read about AHRQ research on IMRT.
Through R&D, the organizations will target cost-effective innovation
Checking in on radiation safety over two years after the international conference
UChicago Medicine appoints inaugural chair of the department of neurological surgery
Momentum building for proton therapy — and its major OEMs
